Published in Br J Pharmacol on February 01, 1970
Mediators of passive lung anaphylaxis in the rat. Br J Pharmacol (1975) 1.14
Release of dopamine from bovine lung by specific antigen and by compound 48-80. Br J Pharmacol (1971) 1.10
Pharmacological significance of biogenic amines in the lungs: noradrenaline and dopamine. Br J Pharmacol (1970) 1.08
The metabolism of 5-hydroxytryptamine and beta-phenylethylamine in perfused rat lung and in vitro. Br J Pharmacol (1979) 1.07
Pharmacological significance of biogenic amines in the lungs: histamine. Br J Pharmacol (1970) 0.91
5-Hydroxytryptamine induces relaxation of goat pulmonary veins: evidence for the noninvolvement of M and D-tryptamine receptors. Br J Pharmacol (1981) 0.88
The nature of the vaso-dilator constituents of certain tissue extracts. J Physiol (1927) 56.41
A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther (1959) 16.61
p-Chlorophenylalanine: a specific depletor of brain serotonin. J Pharmacol Exp Ther (1966) 5.52
The estimation of 5-hydroxytryptamine (serotonin) in biological tissues. J Biol Chem (1955) 3.28
5-Hydroxytryptamine and tissue mast cells. J Physiol (1957) 3.02
The effects of 5-hydroxytryptamine and its antagonists on tidal air. Br J Pharmacol Chemother (1956) 2.73
Pharmacological actions of synthetic 5-hydroxytryptamine (serotonin, thrombocytin). Nature (1952) 2.72
The occurrence, distribution and physiological role of catecholamines in the nervous system. Pharmacol Rev (1959) 2.69
Reflex and direct cardiopulmonary effects of 5-OH-tryptamine (serotonin); their possible role in pulmonary embolism and coronary thrombosis. Am J Physiol (1953) 2.55
Identification and chemical assay of norepinephrine in brain and other tissues. J Pharmacol Exp Ther (1958) 2.37
A simplified method for measuring serotonin in tissues; simultaneous assay of both serotonin and histamine. J Biol Chem (1958) 1.51
Serotonin and histamine release during anaphylaxis in the rabbit. J Clin Invest (1957) 1.50
Dopamine in mammalian lung and spleen. Acta Physiol Pharmacol Neerl (1957) 1.44
The antagonism between local anaesthetic drugs and 5-hydroxytryptamine. J Pharm Pharmacol (1953) 1.40
Presence of serotonin in lung and its implication in the anaphylactic reaction. Science (1957) 1.20
ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS. Can Med Assoc J (1964) 1.17
The 5-hydroxytryptamine shock in the guinea-pig. J Physiol (1955) 1.14
Serotonin in the developing mammal. J Gen Physiol (1962) 1.11
Pharmacological significance of biogenic amines in the lungs: noradrenaline and dopamine. Br J Pharmacol (1970) 1.08
The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine. J Pharmacol Exp Ther (1965) 1.07
Histochemical and chemical studies of the localization of adrenergic and cholinergic nerves in normal and denervated cat hearts. Circ Res (1967) 1.03
Prevention of pulmonary emphysema in rats by progesterone. J Pharmacol Exp Ther (1968) 0.94
Pharmacological significance of biogenic amines in the lungs: histamine. Br J Pharmacol (1970) 0.91
[Bronchoconstrictive effect of serotonin]. Klin Wochenschr (1956) 0.89
Serotonin (5-hydroxytryptamine) and pulmonary thromboembolism. Surg Gynecol Obstet (1959) 0.89
The subcellular localization of histamine in guinea pig brain--a re-evaluation. Biochem Pharmacol (1967) 0.83
Changes in pulmonary mechanics induced by melatonin. Life Sci (1965) 0.78
Pharmacological significance of biogenic amines in the lungs: noradrenaline and dopamine. Br J Pharmacol (1970) 1.08
Cholinergic systems in non-nervous tissues. Pharmacol Rev (1978) 1.07
Pharmacological significance of biogenic amines in the lungs: histamine. Br J Pharmacol (1970) 0.91
Pathologic physiology and chemotherapy of Plasmodium berghei. VI. Mechanical properties and histological features of the lung. Exp Parasitol (1969) 0.81
Inotropic actions of lignocaine and phenytoin. Br J Pharmacol (1971) 0.81
Modification of relative potencies of beta-adrenoceptor agonists by negative chronotropic agents in rat atrium. Gen Pharmacol (1977) 0.80
Challenge of clinical pharmacology in developing countries. J Clin Pharmacol (1981) 0.80
Cardiopulmonary effects of antimalarial drugs. 1. 4-Aminoquinolines: chloroquine quinetholate. Toxicol Appl Pharmacol (1970) 0.77
Antagonism of the effect of isoprenaline on heart rate by pilocarpine. Br J Pharmacol (1974) 0.75
Mechanism of catecholamine antagonism in rat heart produced by pilocarpine and related drugs. Br J Pharmacol (1974) 0.75
Correlation between positive chronotropic effect and norepinephrine release induced by acetone in the rat right atrium. Toxicol Lett (1987) 0.75
Clinical pharmacology: the end or a new beginning? Int J Clin Pharmacol Ther Toxicol (1985) 0.75
Influence of chloroquine and phenanthrene methanols (WR 33,063) on content of biogenic amines in the mouse lung. Mil Med (1969) 0.75
Cigarette smoke and pulmonary emphysema. Influence of bronchodilators and biogenic amines in experimental induction in rats. Arch Environ Health (1970) 0.75
Adrenoceptor subtypes and their cholinoceptor-induced blockades in mammalian atria. Gen Pharmacol (1979) 0.75